Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Pediatric Pathology & Molecular Medicine
|
December 25, 2003
Divergent patterns of extracellular matrix protein expression in neonatal versus adult liver fibrosis
Leonid Zeitlin, Murray B Resnick, Fred Konikoff, et al.
Orphanet Journal of Rare Diseases
|
January 8, 2026
Burosumab in infants with X-linked hypophosphatemic rickets: a case series
Ravit Regev, Avivit Brener, Nitzan Dror, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 19, 2023
Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE-PD Open-Label Extension Study
Alberto J Espay, Robert A Hauser, Rohit Dhall, et al.
Rheumatology (Oxford, England)
|
May 11, 2024
Long-term use of interleukin-1 inhibitors reduce flare activity in patients with fibrodysplasia ossificans progressiva
Ruby Haviv, Leonid Zeitlin, Veronica Moshe, et al.
Orphanet Journal of Rare Diseases
|
October 26, 2023
XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH)
Lothar Seefried, Ali Alzahrani, Pedro Arango Sancho, et al.
Frontiers in Pediatrics
|
December 17, 2024
Nephrocalcinosis tendency does not worsen under burosumab treatment for X-linked hypophosphatemic rickets: a multicenter pediatric study
Shelly Levi, Daniel Landau, Miriam Davidovits, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 5, 2017
PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization
Anders J Kämpe, Alice Costantini, Yael Levy-Shraga, et al.
European Journal of Pediatrics
|
September 14, 2023
Linear growth of children with X-linked hypophosphatemia treated with burosumab: a real-life observational study
Yael Levy-Shraga, Shelly Levi, Ravit Regev, et al.
JAMA Neurology
|
August 14, 2023
IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease: The RISE-PD Randomized Clinical Trial
Robert A Hauser, Alberto J Espay, Aaron L Ellenbogen, et al.
Journal of Human Genetics
|
July 16, 2024
Heterozygous mutations in the straitjacket region of the latency-associated peptide domain of TGFB2 cause Camurati-Engelmann disease type II
Zheng Wang, Mitsuhiro Kometani, Leonid Zeitlin, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Pediatric Pathology & Molecular Medicine
|
December 25, 2003
Divergent patterns of extracellular matrix protein expression in neonatal versus adult liver fibrosis
Leonid Zeitlin, Murray B Resnick, Fred Konikoff, et al.
Orphanet Journal of Rare Diseases
|
January 8, 2026
Burosumab in infants with X-linked hypophosphatemic rickets: a case series
Ravit Regev, Avivit Brener, Nitzan Dror, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 19, 2023
Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE-PD Open-Label Extension Study
Alberto J Espay, Robert A Hauser, Rohit Dhall, et al.
Rheumatology (Oxford, England)
|
May 11, 2024
Long-term use of interleukin-1 inhibitors reduce flare activity in patients with fibrodysplasia ossificans progressiva
Ruby Haviv, Leonid Zeitlin, Veronica Moshe, et al.
Orphanet Journal of Rare Diseases
|
October 26, 2023
XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH)
Lothar Seefried, Ali Alzahrani, Pedro Arango Sancho, et al.
Frontiers in Pediatrics
|
December 17, 2024
Nephrocalcinosis tendency does not worsen under burosumab treatment for X-linked hypophosphatemic rickets: a multicenter pediatric study
Shelly Levi, Daniel Landau, Miriam Davidovits, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 5, 2017
PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization
Anders J Kämpe, Alice Costantini, Yael Levy-Shraga, et al.
European Journal of Pediatrics
|
September 14, 2023
Linear growth of children with X-linked hypophosphatemia treated with burosumab: a real-life observational study
Yael Levy-Shraga, Shelly Levi, Ravit Regev, et al.
JAMA Neurology
|
August 14, 2023
IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease: The RISE-PD Randomized Clinical Trial
Robert A Hauser, Alberto J Espay, Aaron L Ellenbogen, et al.
Journal of Human Genetics
|
July 16, 2024
Heterozygous mutations in the straitjacket region of the latency-associated peptide domain of TGFB2 cause Camurati-Engelmann disease type II
Zheng Wang, Mitsuhiro Kometani, Leonid Zeitlin, et al.
Page
of 4